These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


247 related items for PubMed ID: 25079699

  • 1. Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission.
    Volokhina EB, Westra D, van der Velden TJ, van de Kar NC, Mollnes TE, van den Heuvel LP.
    Clin Exp Immunol; 2015 Aug; 181(2):306-13. PubMed ID: 25079699
    [Abstract] [Full Text] [Related]

  • 2. Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.
    Westra D, Volokhina EB, van der Molen RG, van der Velden TJ, Jeronimus-Klaasen A, Goertz J, Gracchi V, Dorresteijn EM, Bouts AH, Keijzer-Veen MG, van Wijk JA, Bakker JA, Roos A, van den Heuvel LP, van de Kar NC.
    Pediatr Nephrol; 2017 Feb; 32(2):297-309. PubMed ID: 27718086
    [Abstract] [Full Text] [Related]

  • 3. An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome.
    Galbusera M, Noris M, Gastoldi S, Bresin E, Mele C, Breno M, Cuccarolo P, Alberti M, Valoti E, Piras R, Donadelli R, Vivarelli M, Murer L, Pecoraro C, Ferrari E, Perna A, Benigni A, Portalupi V, Remuzzi G.
    Am J Kidney Dis; 2019 Jul; 74(1):56-72. PubMed ID: 30851964
    [Abstract] [Full Text] [Related]

  • 4. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
    Hyvärinen S, Meri S, Jokiranta TS.
    Blood; 2016 Jun 02; 127(22):2701-10. PubMed ID: 27006390
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management.
    Sridharan M, Go RS, Willrich MAV.
    J Immunol Methods; 2018 Oct 02; 461():15-22. PubMed ID: 30031798
    [Abstract] [Full Text] [Related]

  • 7. Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).
    Watson R, Wearmouth E, McLoughlin AC, Jackson A, Ward S, Bertram P, Bennaceur K, Barker CE, Pappworth IY, Kavanagh D, Lea SM, Atkinson JP, Goodship TH, Marchbank KJ.
    Mol Immunol; 2015 Feb 02; 63(2):287-96. PubMed ID: 25150608
    [Abstract] [Full Text] [Related]

  • 8. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
    Song D, Yu XJ, Wang FM, Xu BN, He YD, Chen Q, Wang SX, Yu F, Song WC, Zhao MH.
    Am J Reprod Immunol; 2015 Oct 02; 74(4):345-56. PubMed ID: 26011580
    [Abstract] [Full Text] [Related]

  • 9. Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding.
    Volokhina E, Westra D, Xue X, Gros P, van de Kar N, van den Heuvel L.
    Pediatr Nephrol; 2012 Sep 02; 27(9):1519-24. PubMed ID: 22669319
    [Abstract] [Full Text] [Related]

  • 10. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C.
    Rev Med Interne; 2011 Apr 02; 32(4):232-40. PubMed ID: 21376430
    [Abstract] [Full Text] [Related]

  • 11. Dynamics of complement activation in aHUS and how to monitor eculizumab therapy.
    Noris M, Galbusera M, Gastoldi S, Macor P, Banterla F, Bresin E, Tripodo C, Bettoni S, Donadelli R, Valoti E, Tedesco F, Amore A, Coppo R, Ruggenenti P, Gotti E, Remuzzi G.
    Blood; 2014 Sep 11; 124(11):1715-26. PubMed ID: 25037630
    [Abstract] [Full Text] [Related]

  • 12. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, Grinyó JM, Macía M, Mendizábal S, Praga M, Román E, Torra R, Valdés F, Vilalta R, Rodríguez de Córdoba S.
    Nefrologia; 2015 Sep 11; 35(5):421-47. PubMed ID: 26456110
    [Abstract] [Full Text] [Related]

  • 13. Practical issues in using eculizumab for children with atypical haemolytic uraemic syndrome in the acute phase: A review of four patients.
    Terano C, Ishikura K, Hamada R, Yoshida Y, Kubota W, Okuda Y, Shinozuka S, Harada R, Iyoda S, Fujimura Y, Hamasaki Y, Hataya H, Honda M.
    Nephrology (Carlton); 2018 Jun 11; 23(6):539-545. PubMed ID: 28387984
    [Abstract] [Full Text] [Related]

  • 14. High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B.
    Pouw RB, Gómez Delgado I, López Lera A, Rodríguez de Córdoba S, Wouters D, Kuijpers TW, Sánchez-Corral P.
    Front Immunol; 2018 Jun 11; 9():848. PubMed ID: 29740447
    [Abstract] [Full Text] [Related]

  • 15. Complement factor H functional assay may help to monitor atypical haemolytic uraemic syndrome: a pilot study.
    Massart A, Golmarvi S, Hachimi-Idrissi S, Broeders E, Tournay Y, Nortier J, Abramowicz D, Tielemans C, Stordeur P.
    Acta Clin Belg; 2013 Jun 11; 68(1):9-14. PubMed ID: 23627188
    [Abstract] [Full Text] [Related]

  • 16. Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutation.
    Ueda Y, Miwa T, Ito D, Kim H, Sato S, Gullipalli D, Zhou L, Golla M, Song D, Dunaief JL, Palmer MB, Song WC.
    Kidney Int; 2019 Jul 11; 96(1):67-79. PubMed ID: 30910380
    [Abstract] [Full Text] [Related]

  • 17. Modeling complement activation on human glomerular microvascular endothelial cells.
    Stevens KH, Baas LM, van der Velden TJAM, Bouwmeester RN, van Dillen N, Dorresteijn EM, van Zuilen AD, Wetzels JFM, Michels MAHM, van de Kar NCAJ, van den Heuvel LP.
    Front Immunol; 2023 Jul 11; 14():1206409. PubMed ID: 37954621
    [Abstract] [Full Text] [Related]

  • 18. Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.
    Mohlin FC, Nilsson SC, Levart TK, Golubovic E, Rusai K, Müller-Sacherer T, Arbeiter K, Pállinger É, Szarvas N, Csuka D, Szilágyi Á, Villoutreix BO, Prohászka Z, Blom AM.
    Mol Immunol; 2015 Jun 11; 65(2):367-76. PubMed ID: 25733390
    [Abstract] [Full Text] [Related]

  • 19. Anti-complement-factor H-associated glomerulopathies.
    Durey MA, Sinha A, Togarsimalemath SK, Bagga A.
    Nat Rev Nephrol; 2016 Sep 11; 12(9):563-78. PubMed ID: 27452363
    [Abstract] [Full Text] [Related]

  • 20. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.
    Huerta A, Arjona E, Portoles J, Lopez-Sanchez P, Rabasco C, Espinosa M, Cavero T, Blasco M, Cao M, Manrique J, Cabello-Chavez V, Suñer M, Heras M, Fulladosa X, Belmar L, Sempere A, Peralta C, Castillo L, Arnau A, Praga M, Rodriguez de Cordoba S.
    Kidney Int; 2018 Feb 11; 93(2):450-459. PubMed ID: 28911789
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.